Baker Bros. Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Sell |
|
|||||
|
2025
Q1 | $22.2M | Sell |
|
|||||
|
2024
Q4 | $30.5M | Hold |
|
|||||
|
2024
Q3 | $31.5M | Hold |
|
|||||
|
2024
Q2 | $25.7M | Sell |
|
|||||
|
2024
Q1 | $68.5M | Buy |
|
|||||
|
2023
Q4 | $55.3M | Hold |
|
|||||
|
2023
Q3 | $120M | Hold |
|
|||||
|
2023
Q2 | $111M | Hold |
|
|||||
|
2023
Q1 | $90.6M | Hold |
|
|||||
|
2022
Q4 | $130M | Hold |
|
|||||
|
2022
Q3 | $80.6M | Buy |
|
|||||
|
2022
Q2 | $1.12M | Hold |
|
|||||
|
2022
Q1 | $1.68M | Hold |
|
|||||
|
2021
Q4 | $2.5M | Hold |
|
|||||
|
2021
Q3 | $2.65M | Hold |
|
|||||
|
2021
Q2 | $2.94M | Hold |
|
|||||
|
2021
Q1 | $3.43M | Hold |
|
|||||
|
2020
Q4 | $3.05M | Sell |
|
|||||
|
2020
Q3 | $4.06M | Buy |
|